Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Rodrigo E. Mendes
Updating Molecular Diagnostics for Detecting Methicillin-Susceptible and Methicillin-Resistant Staphylococcus Aureus in Blood Culture Bottles
Journal of Clinical Microbiology
Microbiology
Antimicrobial Activities of Ceftaroline and Comparator Agents Against Bacterial Organisms Causing Bacteremia in Patients With Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Comparative Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Against Enterobacteriaceae Isolates Producing Extended-Spectrum Β-Lactamases From United States Hospitals
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antimicrobial Activity of Ceftazidime-Avibactam Tested Against Multidrug-Resistant Enterobacteriaceae and Pseudomonas Aeruginosa Isolates From United States Medical Centers (2013--2016)
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Low Prevalence of Gram-Positive Isolates Showing Elevated Lefamulin MIC Results During the Surveillance Program for 2015–2016 and Characterization of Resistance Mechanisms
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Antimicrobial Activity Evaluation of Tebipenem (SPR859), an Orally Available Carbapenem, Against a Global Set of Enterobacteriaceae, Including a Challenge Set of Organisms
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Molecular Epidemiology of Staphylococcus Epidermidis Clinical Isolates From U.S. Hospitals
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Prevalence of -Lactamase-Encoding Genes Among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report From the SENTRY Antimicrobial Surveillance Program (2010)
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens From 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions
Microbial Drug Resistance
Medicine
Immunology
Microbiology
Pharmacology
Distribution of Main Gram-Positive Pathogens Causing Bloodstream Infections in United States and European Hospitals During the SENTRY Antimicrobial Surveillance Program (2010–2016): Concomitant Analysis of Oritavancin in Vitro Activity
Journal of Chemotherapy
Medicine
Oncology
Infectious Diseases
Pharmacology
1
2
›